Pfizer’s initial clinical trials on the drug were conducted on unvaccinated adults.
Data suggest Paxlovid doesn’t reduce severe COVID in older, vaccinated adults
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- Health leaders from multiple prior administrations sound alarm over CDC cuts
- COVID-19 may put patients at risk for other infections for at least 1 year
- COVID-19 re-infection doubles risk of long COVID in kids, young adults, data reveal
- Healthcare workers with chronic condition miss more days of work due to COVID than flu, data show